Alerts will be sent to your verified email
Verify EmailORTINGLOBE
Ortin Global
|
Beryl Drugs
|
Cian Healthcare
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-57.26 % | 2.54 % | -2.49 % |
5yr average Equity Multiplier
|
2.67 | 2.23 | 2.79 |
5yr Average Asset Turnover Ratio
|
0.6 | 1.08 | 0.42 |
5yr Avg Net Profit Margin
|
-75.26 % | 0.66 % | -2.06 % |
Price to Book
|
4.0 | 1.01 | 0.0 |
P/E
|
0.0 | 113.66 | 34.21 |
5yr Avg Cash Conversion Cycle
|
597.13 Days | -619.24 Days | -692.15 Days |
Inventory Days
|
335.19 Days | 36.1 Days | 163.23 Days |
Days Receivable
|
448.05 Days | 98.89 Days | 131.14 Days |
Days Payable
|
649.97 Days | 969.29 Days | 473.59 Days |
5yr Average Interest Coverage Ratio
|
-2.05 | 1.68 | 0.8 |
5yr Avg ROCE
|
-24.19 % | 5.73 % | 5.59 % |
5yr Avg Operating Profit Margin
|
-55.65 % | 7.19 % | 14.07 % |
5 yr average Debt to Equity
|
0.64 | 0.64 | 1.12 |
5yr CAGR Net Profit
|
44.41 % | 72.78 % | n/a |
5yr Average Return on Assets
|
-20.66 % | 1.31 % | -0.86 % |
Shareholdings
|
|||
Promoter Holding
|
1.23 % | 26.38 % | 27.1 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 34.48 % |
Change in Promoter Holding (3 Yrs)
|
-14.45 % | 1.46 % | -43.79 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Ortin Global
|
Beryl Drugs
|
Cian Healthcare
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|